Role of Coping With Symptoms in Depression and Disability: Comparison Between Inflammatory Bowel Disease and

Miranda A L van Tilburg1, Robyn L Claar, Joan M Romano

  • 1*Center for Functional Gastrointestinal and Motility Disorders, University of North Carolina, Chapel Hill, NC †School of Social Work ‡Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA §Department of Pediatrics, Vanderbilt University, Nashville, TN ||Prime Health Clinic, Puyallup ¶Division of Pediatric Gastroenterology, Seattle Children's Hospital, University of Washington School of Medicine, Seattle WA.

Insights

Children with functional abdominal pain (AP) use more coping strategies than those with inflammatory bowel disease (IBD). Maladaptive coping, like catastrophizing, is linked to depression and disability in both pediatric groups.

Area of Science:

  • Pediatric Gastroenterology
  • Child Psychology
  • Health Outcomes Research

Background:

  • Inflammatory bowel disease (IBD) and functional abdominal pain (AP) are prevalent pediatric gastrointestinal disorders.
  • These conditions increase the risk of depression and disability in children.
  • Symptom severity and coping mechanisms may influence these adverse outcomes.

Purpose of the Study:

  • To compare coping strategies used by children with AP versus IBD.
  • To investigate the relationship between coping strategies, depression, and functional disability, independent of symptom severity.

Main Methods:

  • Secondary data analysis of two existing datasets.
  • Included 200 children with AP and 189 children with IBD.
  • Analyzed coping strategies, depression, and functional disability, controlling for symptom severity, age, and sex.

Main Results:

  • Children with AP reported greater use of self-isolation, behavioral disengagement, catastrophizing, problem-solving, and social support seeking compared to IBD patients.
  • Coping strategies were associated with depression and functional disability in both groups, independent of symptom severity.
  • Catastrophizing specifically predicted depression and disability in both pediatric samples.

Conclusions:

  • Children with AP utilize a wider range of coping strategies than those with IBD.
  • Specific coping mechanisms, especially catastrophizing, are linked to increased depression and functional disability in both IBD and AP.
  • Awareness of maladaptive coping is crucial for clinicians managing pediatric patients with these conditions.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
950
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.4K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
986